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OBJECTIVES The purpose of this time-domain study was to compare pulmonary artery (PA) pulse pressure
and wave reflection in chronic pulmonary thromboembolism (CPTE) and primary pulmonary
hypertension (PPH).
BACKGROUND Pulmonary artery pressure waveform analysis provides a simple and accurate estimation of
right ventricular afterload in the time-domain. Chronic pulmonary thromboembolism and
PPH are both responsible for severe pulmonary hypertension. Chronic pulmonary thrombo-
embolism and PPH predominantly involve proximal and distal arteries, respectively, and may
lead to differences in PA pressure waveform.
METHODS High-fidelity PA pressure was recorded in 14 patients (7 men/7 women, 46 6 14 years) with
CPTE (n 5 7) and PPH (n 5 7). We measured thermodilution cardiac output, mean PA
pressure (MPAP), PA pulse pressure (PAPP 5 systolic 2 diastolic PAP) and normalized
PAPP (nPAPP 5 PPAP/MPAP). Wave reflection was quantified by measuring Ti, that is,
the time between pressure upstroke and the systolic inflection point (Pi), DP, that is, the
systolic PAP minus Pi difference, and the augmentation index (DP/PPAP).
RESULTS At baseline, CPTE and PPH had similar cardiac index (2.4 6 0.4 vs. 2.5 6 0.5 l/min/m2),
mean PAP (59 6 9 vs. 59 6 10 mm Hg), PPAP (57 6 13 vs. 53 6 13 mm Hg) and
nPPAP (0.97 6 0.16 vs. 0.89 6 0.13). Chronic pulmonary thromboembolism had shorter Ti
(90 6 17 vs. 126 6 16 ms, p , 0.01) and higher DP/PPAP (0.26 6 0.01 vs. 0.09 6 0.07,
p , 0.01).
CONCLUSIONS Our study indicated that: 1) CPTE and PPH with severe pulmonary hypertension had similar
PA pulse pressure, and 2) wave reflection is elevated in both groups, and CPTE had increased
and anticipated wave reflection as compared with PPH, thus suggesting differences in the
pulsatile component of right ventricular afterload. (J Am Coll Cardiol 2001;37:1085–92)
© 2001 by the American College of Cardiology
Primary pulmonary hypertension (PPH) and chronic pul-
monary thromboembolism (CPTE) are both responsible for
severe chronic pulmonary hypertension. In these two dis-
eases, the mechanism of death is mainly right ventricular
failure (1–3). Therefore, it is of major importance to
improve our understanding of right ventricular afterload in
PPH and CPTE. Chronic pulmonary hypertension results
from an increase in pulmonary vascular resistance, which is
a simple measure of the opposition to the mean component
of flow. However, given the low resistance/high compliance
nature of pulmonary circulation, the pulsatile component of
hydraulic load is also important to consider (4,5). Several
studies have documented the relationship between pulsatile
pressure and flow (impedance) in the frequency domain.
They have shown that the pulsatile load is also increased in
chronic pulmonary hypertension, as attested to by the
increased characteristic impedance and enhanced wave re-
flection (6–10). This has generally been attributed to
decreased pulmonary artery (PA) compliance and complex
changes in reflection sites. In pulmonary hypertension,
Milnor et al. (6) have pointed out that decreased PA
compliance is of similar importance to increased resistance
in the elevation of right ventricular afterload. This abnormal
pulsatile load may have detrimental effects on ventricular-
vascular coupling by increasing the pulsatile part of ventric-
ular power and, thus, unfavorably loading the still-ejecting
right ventricle (5–10).
Impedance is not easy to assess in clinical practice, and,
therefore, the pulsatile component of right ventricular af-
terload is generally ignored in patients with chronic pulmo-
nary hypertension. Taking into account both these technical
limitations and certain limitations of Fourier analysis (11), it
has recently been suggested that time-domain analysis of
pulse pressure and pressure waveform could provide valuable
information on pulsatile arterial load (11–13). Pulse pres-
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sure (i.e., systolic minus diastolic pressure) indicates the
amplitude of pulsatile stress. Pulse pressure is mainly deter-
mined by both the characteristics of ventricular ejection and
arterial compliance, such that the lower the compliance, the
higher the pulse pressure in both aorta (14–17) and PA
(5,18,19). Moreover, pressure waveform analysis performed
in the time-domain makes it possible to calculate the timing
and extent of wave reflection in systemic (20,21) and
pulmonary (12,13) circulation.
The first aim of this study was to compare PA pulse
pressure (PAPP) in PPH and CPTE. The rationale was
that PPH and CPTE lead to severe pulmonary hyperten-
sion via different mechanisms. In PPH, pulmonary obstruc-
tive vasculopathy involves distal, medium-to-small sized
muscular (resistive) arteries. By contrast, in CPTE, the
thrombi follow an aberrant path of organization and recan-
alization, leaving endothelialized residua that narrow and
stiffen major (main, lobar or segmental) pulmonary arteries,
that is, elastic arteries (1–3). These pathophysiological
differences could lead to differences in the pulsatile compo-
nent of hydraulic load (22–26). Cardiac ejection into a low
compliance system generates a higher pulse pressure than in
a normally compliant system (27–29). Furthermore, con-
striction of the main PA is associated with a higher PAPP
than in the case of distal obstruction as determined in a
study of distal artery microembolization in dogs with
comparable PA hypertension severity (25). Thus, we tested
the hypothesis that the PAPP would be higher in CPTE
than it would be in PPH.
The second aim of our study was to compare wave
reflection in PPH and CPTE. The timing of the return of
the reflection wave to the entrance of the pulmonary bed is
a function of the distance to the reflected site(s) and pulse
wave velocity (30,31). The composite reflection wave has
been shown to arrive during the diastolic period in healthy
subjects and during the midportion of right ventricular
ejection time in PPH (6,8,10,12,13). Thus, we hypothe-
sized that abnormal mechanical properties and geometry of
proximal arteries would lead to early, enhanced wave reflec-
tion in CPTE versus PPH. The distending mean PA
pressure (MPAP) being a contributory factor in both PA
compliance and pulse wave velocity (5,31), CPTE and PPH
were, therefore, matched for MPAP.
METHODS
Patients. The study was approved by the ethics board of
Paris-Sud University, and informed consent was obtained
for all patients. From December 1996 to July 1997, 14
consecutive patients referred to our catheterization labora-
tory for severe pulmonary hypertension were studied. The
study population comprised patients with PPH (n 5 7) or
CPTE (n 5 7). There were seven men and seven women
(mean age 6 SD 5 46 6 14 years). Pulmonary hyperten-
sion was defined by an MPAP in excess of 25 mm Hg at rest
in room air and with a mean pulmonary occlusion pressure
#12 mm Hg at right-sided catheterization. Primary pul-
monary hypertension was diagnosed according to the crite-
ria of the National Institutes of Health Patient Registry for
the Catheterization of Primary Pulmonary Hypertension
(32). Secondary causes of pulmonary hypertension were
excluded after thorough clinical and laboratory evaluations,
chest radiography, pulmonary function testing, echocardi-
ography and perfusion lung scan or pulmonary angiography
(32). Chronic pulmonary thromboembolism diagnosis was
based on the existence of multiple perfusion defects on the
perfusion lung scan and a typical angiographic pattern, that
is, pouchings, webs, stenosis, parietal irregularities, abrupt
narrowing and vascular amputations (33). All patients were
given anticoagulants. No patient was undergoing vasodilator
treatment at the time of the study. Patients with right-to-
left interatrial shunting or with significant tricuspid insuf-
ficiency on echocardiography were excluded from the study.
Catheterization technique. Hemodynamic evaluation was
carried out on supine patients breathing room air, according
to our routine protocol (34,35). Right heart catheterization
was performed using the Seldinger technique with an 8F
sheath via the jugular or basilic vein. The right heart
catheter was a 7.5F, 2 lumen, thermodilution pressure-
measuring tipped catheter with a high-fidelity transducer
(Cordis/Sentron, Roden, the Netherlands) (36,37). The
Sentron system has a frequency bandwidth of 0 to 180 Hz,
and good agreement between the system and Millar mi-
crotip catheter has been previously demonstrated in both the
time-domain and the frequency-domain (36). Pressure data
were computed on a Toshiba 3200 SX, and we used a
sampling frequency of 1,000 Hz, without filtering of the
analog signal, as previously recommended (36). Filtering at
half the digitization rate is known to avoid aliasing. How-
ever, it is unlikely that it would have any impact on our
measurements (36). The catheter was placed into either the
right or left PA. Cardiac output was measured in triplicate
by the thermodilution technique (34). Pulmonary artery
blood samples were taken for measurements of mixed
venous oxygen saturation. Electrocardiogram was moni-
tored continuously. Respiratory cycles were determined with
a respiratory inductive photoplethysmograph (Respitrace,
Ambulatory Monitoring, Arsley, New Jersey).
High-fidelity PA pressures (Fig. 1). Mean pulmonary
artery pressure was defined as the area under the pressure
Abbreviations and Acronyms
b.s.a. 5 body surface area
CPTE 5 chronic pulmonary thromboembolism
DPAP 5 diastolic pulmonary artery pressure
dP/dt 5 pressure derivative
MPAP 5 mean pulmonary artery pressure
PA 5 pulmonary artery
PAPP 5 pulmonary artery pulse pressure
PPH 5 primary pulmonary hypertension
SPAP 5 systolic pulmonary artery pressure
TPR 5 total pulmonary resistance
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curve divided by the pulse interval. Systolic PA pressure
(SPAP) was determined automatically by the computer
analysis. The onset of pressure pulse and the corresponding
diastolic PA pressure (DPAP) was identified in all the
patients as the time when pressure derivative (dP/dt) in-
creased steeply. The intra- and interobserver variability for
DPAP measurements was 6 6 4% and 1 6 1%, respectively.
We calculated PAPP (PAPP 5 SAPP 2 DAPP). Mean
pressure and pulse pressure reflect, respectively, the steady
and pulsed components of the PA pressure (4,38,39). Given
that the higher the mean pressure, the lower the arterial
compliance and, thus, the higher the fluctuations around the
mean, we calculated the PAPP/MPAP ratio. Pulmonary
artery occlusion pressure was determined according to
standard procedures. However, given the severity of pulmo-
nary hypertension, it was possible to record PA occlusion
pressure in 4/7 CPTE (12 6 4 mm Hg) and 5/7 PPH
(11 6 2 mm Hg, p 5 0.6) only. Total pulmonary resistance
(TPR) was calculated as TPR 5 MPAP/cardiac output.
The TPRi was calculated as the TPR/body surface area
(b.s.a.) ratio.
Wave reflection: background. Pulmonary artery pulse
wave velocity is around 2 m/s at normal distending pressure,
such a value being about half that usually reported in the
aorta (31). In both the aorta and the PA of healthy humans,
the composite reflected pressure wave arrives during the
early diastolic period because the shorter path length in the
pulmonary circulation compensates for the relatively lower
pulse wave velocity (20,27,31). An increase in pulse wave
velocity has been noted when the distending, MPAP
increases (6,40). In patients with pulmonary hypertension,
this was considered partially due to a direct effect on the
large arteries (6) or to a passive phenomenon resulting from
greater stretch of the vessel with transfer of tension from the
elastic to collagenous component of the wall (31).
Timing and extent of wave reflection (Fig. 1). The timing
and extent of wave reflection were quantified by using
pressure waveform analysis in the time-domain, as previ-
ously described (12,13,20). Indeed, Murgo et al. (20) have
shown: 1) that the magnitude of the secondary rise in the
aortic pressure waveform appears to be directly related to the
magnitude of the oscillations in the impedance spectra and
2) that the transit time derived from the pressure data is
inversely related to both the frequency at which the first
minimum of the impedance modulus occurs and to the
transit time derived from impedance data. This approach
has recently been extended to pulmonary circulation
(12,13). The human pulmonary pressure systolic waveform
may exhibit an inflection point (Pi) that results from peak
flow input into the vasculature before the effects of wave
reflection. Pi indicates the end of the forward (or incident)
pressure wave. The relative increase in pressure amplitude
above the inflection point (DP 5 SPAP 2 Pi) is an estimate
of the magnitude of the reflected pressure wave. The ratio of
DP to PAPP defines a so-called augmentation index (DP/
PAPP) (12,13,20). In normal subjects, there is very little
wave reflection. Otherwise, the DP/PAPP ratio can be used
to precisely quantify the extent of wave reflection in PA
(12,13).
In this study, we calculated Pi, DP, DP/PAPP and the
so-called transit time (Ti), that is, the time between pressure
upstroke and Pi. In the majority of patients (11/14), the
inflection in pressure was smooth, such that the first
derivative (dP/dt) did not cross zero. As a result, the
inflection point was defined as the time at which the dP/dt
reached its first minimum. In the remaining 3/14 patients
(two with CPTE, one with PPH), the pressure inflection
was sharp, such that the dP/dt value at the time of inflection
crossed zero. In these patients, the inflection point was
defined as the time when the dP/dt crosses zero for the
second time. Given that Ti is influenced by the systolic
time, we calculated the pressure-derived systolic time be-
tween pressure upstroke and the PA incisura. The PA
incisura corresponds to pulmonary valve closure and the
Figure 1. Typical pulmonary artery pressure tracings. DPAP 5 diastolic pulmonary artery pressure; PAPP 5 pulmonary artery pulse pressure; Pi 5
pulmonary artery pressure at the inflexion point; SPAP 5 systolic pulmonary artery pressure; Ti 5 transit time. For Pi and Ti calculations, see Methods
section.
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pulmonary component of the second sound. We, thus,
calculated the Ti/systolic time ratio. As Ti is also influenced
by the dimension of the vascular tree, we calculated the
Ti/b.s.a. ratio. For Pi (mm Hg) measurements, the intra-
and interobserver variability was 1 6 1% and 3 6 1%,
respectively. For Ti (ms) measurements, the intra- and
interobserver variability was 7 6 4% and 4 6 3%, respec-
tively.
Statistical analysis. The data are expressed as means 6
SD. Pressures and time parameters were averaged out over
15 cardiac cycles. Comparisons at baseline were performed
using the Mann-Whitney U test.
RESULTS
The characteristics of the study population are listed in
Table 1. Pulmonary function was normal in the two groups.
Age, sex ratio, heart rate, cardiac index, stroke volume and
mixed venous oxygen saturation were similar in each group.
Pulmonary hypertension was of similar severity in the two
groups, as attested to by similar MPAP and TPRi (Table 1).
Therefore, patients were matched for the steady component
of PA load, thus allowing optimal comparisons of the
pulsatile component of PA pressure.
PAPP. Individual pressure waveform tracings from all 14
patients are presented in Figure 2. The PAPP was similar in
CPTE (57 6 13 mm Hg) and PPH (53 6 13 mm Hg) (p 5
0.56). The normalized PAPP (PAPP/MPAP ratio) was also
similar in CPTE (0.97 6 0.16) and PPH (0.89 6 0.13)
(p 5 0.30). Individual data points are presented in Figure 3,
attesting to major overlap of PAPP indexes, with no cutoff
value between the two groups. The pressure-derived systolic
time was similar in CPTE (292 6 37 ms) and PPH (288 6
36 ms).
Wave reflection. In one of the 14 subjects (belonging to
the PPH group), the inflection point Pi could not be clearly
identified at baseline. Pi was similar in the two groups (p 5
0.31) (Table 2). Pi was strongly related to MPAP in both
CPTE (slope 5 1.15; ordinate 5 111 mm Hg; r 5 0.99)
and PPH (slope 5 1.34: ordinate 5 12 mm Hg; r 5 0.98)
(each p , 0.01). The relative increase in pressure amplitude
above the inflection point (DP) and the augmentation index
DP/PAPP were higher in CPTE than they were in PPH
(each p , 0.01) (Table 2). Wave reflection of varying extent
could be observed within each group (Fig. 2 and 4), in such
a way that there was no cutoff value for DP/PAPP, allowing
discrimination between CPTE and PPH.
The transit time Ti, Ti/systolic time and Ti/b.s.a. were
shorter in CPTE than they were in PPH (each p , 0.01)
(Table 2, Fig. 4). Given that one CPTE and one PPH share
a common value of Ti (98 ms), there was no cutoff value
allowing discrimination between CPTE and PPH. When
the Ti/systolic time ratio was considered, a cutoff value
(0.36) allowed discrimination between the two groups,
without overlap. When the Ti/b.s.a. ratio was considered, a
57 ms/m2 cutoff value allowed discrimination between
CPTE and PPH without overlap (Fig. 4).
DISCUSSION
PAPP in PPH and CPTE. The main result of this study
was that PPH and CPTE patients with pulmonary hyper-
tension of comparable severity had similar pulse pressure
and normalized pulse pressure (i.e., pulse pressure divided
Table 1. Clinical and Hemodynamic Data (n 5 14)
CPTE
(n 5 7)
PPH
(n 5 7)
Age (yrs) 44 6 16 47 6 13
Gender 4M/3F 3M/4F
MPAP (mm Hg) 59 6 9 59 6 10
SPAP (mm Hg) 94 6 16 91 6 17
DPAP (mm Hg) 37 6 7 39 6 6
Heart rate (beats/min) 95 6 16 95 6 15
Cardiac index (l/min/m2) 2.4 6 0.4 2.5 6 0.5
Total pulmonary resistance
(mm Hg/l/min/m2)
25 6 6 24 6 4
SVO2 (%) 57 6 8 62 6 5
Values are means 6 SD.
CPTE 5 chronic pulmonary thromboembolism; DPAP 5 diastolic pulmonary
artery pressure; MPAP 5 mean pulmonary artery pressure; PPH 5 primary
pulmonary hypertension; SPAP 5 systolic pulmonary artery pressure; SVO2 5 mixed
venous oxygen saturation.
Figure 2. Illustration of pulmonary artery pressure waveforms in each of
the 14 patients under study. CPTE 5 chronic pulmonary thromboembo-
lism (n 5 7); PPH 5 primary pulmonary hypertension (n 5 7). Recording
time 5 2 s for each trace.
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by mean pressure). In contrast with our results, a recent
study has reported higher PAPP and normalized pulse
pressure in CPTE than in PPH (26). However, in the
previous study (26), there were major differences in the
severity of pulmonary hypertension (as assessed by MPAP)
between CPTE and PPH, and this confounds pulsatility
comparisons. Other limitations of previous study (26) in-
clude the use of fluid-filled catheters and a retrospective
study design, with almost twice the number of patients with
CPTE than with PPH. Our results are consistent with
other studies suggesting that changes in elasticity and pulse
pressure are primarily due to an increase in MPAP in
pulmonary hypertension (38,39). Given that our patients
had severe pulmonary hypertension of comparable severity,
one hypothesis could be that the PAs approach a similar
limit of compliance in both groups (41). The chronically
hypertensive lung may be an “end-stage” organ, and ad-
vanced pulmonary hypertension of whatever etiology may
appear the same from the viewpoint of PAPP as both
diseases result in major increases in MPAP caused by
obliteration of the pulmonary vascular bed. On the other
hand, we cannot exclude the possibility that pulse pressure is
an index that is not sufficiently sensitive to discriminate
between the potential differences in PA elastic properties in
the two groups.
Cardiac index, heart rate and pressure pulse duration were
similar in each group. This is consistent with the results
showing that right ventricular ejection fraction and contrac-
tility decrease inversely with the level of elevated TPR (42).
It is unlikely that enhanced right ventricular ejection con-
tributed to the increased PAPP, given that stroke volume
was low in the two groups. However, flow pulse was not
recorded in our study, and similar stroke volume in CPTE
and PPH may well be associated with differences in flow
dynamics (e.g., peak velocity and acceleration).
Wave reflection. Abnormal pressure-wave reflection oc-
curring in systole (10) was confirmed in PPH and was
documented for the first time, to the best of our knowledge,
in CPTE. In our study, CPTE exhibited greater wave
reflection (i.e., higher augmentation index) and anticipated
wave reflection (i.e., shorter transit time Ti) as compared
with PPH. After taking into account the influence of b.s.a.,
which is a significant determinant of the dimension of the
pulmonary vascular tree and, thus, wave reflection, a cutoff
value was used to separate the two groups without overlap.
Abnormal mechanical properties and geometry of proximal
(main, lobar or segmental) pulmonary arteries in CPTE
may lead to discontinuity in the caliber and elastic properties
of these arteries, resulting in enhanced and earlier wave
reflections (27). Changing the reflecting sites to a “more
proximal” location may also be involved (8–13,19).
The normal pulmonary circulation exhibits very little
wave reflection (5,8,27). In normally elastic PA, the low
amplitude reflection peaks at or just after the dicrotic notch
and seems to be one of the mechanisms optimizing the right
ventricular-PA coupling (6,8,12,13). Clinical studies per-
formed in the frequency domain have shown that wave
reflection is increased and anticipated under conditions of
Table 2. Indexes of Wave Reflection
CPTE PPH
Pi (mm Hg) 79 6 11 87 6 16
DP 5 SPAP 2 Pi (mm Hg) 15 6 8 5 6 4*
Augmentation index (DP/PAPP) 0.26 6 0.09 0.09 6 0.07†
Ti (ms) 90 6 17 126 6 16†
Ti/systolic time 0.30 6 0.05 0.43 6 0.08†
Ti/b.s.a. (ms/m2) 48 6 8 71 6 10†
Values are means 6 SD. *p , 0.05; †p , 0.01 vs. CPTE.
b.s.a. 5 body surface area; CPTE 5 chronic pulmonary thromboembolism (n 5
7); PAPP 5 pulmonary artery pulse pressure; Pi 5 pulmonary artery pressure systolic
inflection point; PPH 5 primary pulmonary hypertension (n 5 6); SPAP 5 systolic
pulmonary artery pressure; Ti 5 transit time.
Figure 3. Mean pulmonary artery pressure (MPAP), pulmonary artery pulse pressure (PAPP) and normalized pulmonary artery pulse pressure
(PAPP/MPAP) in chronic pulmonary thromboembolism (CPTE) (open circles) and in primary pulmonary hypertension (PPH) (closed circles).
Individual data points and means 6 SD are indicated.
1089JACC Vol. 37, No. 4, 2001 Castelain et al.
March 15, 2001:1085–92 Pulse Pressure in Pulmonary Hypertension
pulmonary hypertension, whether in the setting of PPH
(10), severe left heart failure and mitral stenosis (8,12) or
coronary angioplasty (9). Reflected pressure waves add to
the incident pressure, while flow reflections subtract from
forward flow waves (27). Thus, in experimental and clinical
settings where PA compliance is decreased and pulse wave
velocity is increased, an earlier, increased reflected wave
returns to the PA during systole rather than diastole, and
this could contribute to the increase in PAPP (8–13,25), the
prolonged time-to-peak pressure (43) and the midsystolic
deceleration of pulmonary blood flow (44) in PPH.
Increased wave reflection is believed to be the main
explanation of the midsystolic deceleration (notch) found on
Doppler-derived systolic velocity pulmonary flow curves in
pulmonary hypertension (25,45,46). Although it should be
pointed out that the pressure wave cannot provide precise
information on flow pulse, it is interesting to note that the
mean Ti value we reported in PPH (126 ms) was close to
that of the time-to-notch mean value (125 ms) reported by
Torbicki et al. (46) in a study population of PPH similar to
ours. Turkevich et al. (45) found an inverse correlation
between time-to-notch and the severity of pulmonary hy-
pertension. Others have suggested that some factors other
than elevated PA pressure may be required for production of
midsystolic notching (44) and that a shorter time-to-notch
was mainly due to a more proximal reflection site (25,46).
Consistent with the latter hypothesis, our study indicates
that when patients are matched for MPAP, the more
proximal location of the functional reflection site is associ-
ated with a shorter time-to-peak reflected pressure wave.
Although the main pulmonary branches are thought to be
one major reflection site, it is accepted that reflections from
the pulmonary microcirculation can be at least as important
as those from the branching of large vessels (5). Assuming
a similar pulse wave velocity of 4 m/s in PPH and CPTE
(i.e., a twofold increase in pulse wave velocity in patients
with elevated MPAP versus normotensive ones [40,47,48]),
the Ti measured in our study would imply a functional
reflection point at 25 cm in PPH (Ti 5 126 ms) and 18 cm
in CPTE (Ti 5 90 ms). Turkevich et al. (45) have proposed
that, given a time-to-notch of 120 ms in PPH and assuming
a pulse wave velocity of 5 m/s in PPH, the reflection point
was located at 30 cm, which they considered to be “com-
patible with a locus within the lung.” Obviously, however,
the meaning of such extrapolations must be carefully dis-
cussed, especially in the case of the short pulmonary vessels,
given that the extrapolated locations reflect functional as-
pects of the composite wave reflection phenomenon rather
than true anatomical location of the reflection site(s) (31).
Study limitations. The PA input impedance defined in the
frequency domain represents the most complete description
of vascular hydraulic load (4–6). Although it is well-
recognized that no single parameter can fully describe the
reflection properties of a system of branching viscoelastic
tubes as complex as the pulmonary vasculature (4–6,31),
previous studies have demonstrated the usefulness of time-
domain indexes of wave reflections (4–13,27,30). The fact
that we could differentiate patients with PPH from patients
with CPTE using pressure wave shape analysis at baseline
must be viewed as one of the strengths of the study. The
inflection point could be identified in 86% (6/7) of patients
with PPH and 100% (7/7) of patients with CPTE. Inter-
estingly, midsystolic notching of PA flow velocity was found
in 83% of patients with PPH and 100% of patients with
CPTE in the study by Torbicki et al. (46). Further studies
are needed to determine how time-domain indexes of wave
reflection relate to frequency-domain indexes. The absence
of an inflection point in 1/7 patients with PPH in no way
indicates a lesser degree of wave reflection (43). In one
patient with PPH, the augmentation index approached 0,
Figure 4. Augmentation index (left panel), transit time (Ti) (middle panel) and normalized transit time (right panel) in chronic pulmonary
thromboembolism (CPTE) (open circles) and in primary pulmonary hypertension (PPH) (solid circles). b.s.a. 5 body surface area; Pi 5 pulmonary artery
pressure at the inflexion point; SPAP 5 systolic pulmonary artery pressure. Individual data points and means 6 SD are indicated. Two patients with CPTE
had almost identical Ti values and Ti/b.s.a. values.
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but PA pressure waveform was abnormal; the inflection
point Pi was clearly identified and occurred in midsystole,
thus in keeping with elevated wave reflection. Finally, PPH
and CPTE were matched for MPAP, but relative differ-
ences in the presentation of these patients for medical
attention may also play a role in our results, a point that
deserves further study.
Implications. First, it is suggested that PA pressure
waveform analysis may be useful for distinguishing between
PPH and CPTE, depending on the extent and timing of
wave reflection. Second, in experimental and clinical set-
tings where wave reflection is increased, the ventricular-
vascular coupling is less efficient (8–15,30). In conditions of
comparable severity of pulmonary hypertension, it may be
postulated that more of the total expended power is
“wasted” in oscillations in patients with CPTE than it is in
patients with PPH. Wave reflection unfavorably loaded the
still-ejecting right ventricle in the entire study population,
and this could be more detrimental in CPTE than it is in
PPH since this effect was achieved earlier in the ejection
phase in patients with CPTE. This may lead to differences
in the tolerance of the right ventricle to pulmonary hyper-
tension between CPTE and PPH, a hypothesis that needs
to be confirmed.
Conclusions. Our study indicated that patients with PPH
and CPTE who had severe pulmonary hypertension of
comparable severity had similar PAPP. Wave reflection was
elevated in both groups, and CPTE had increased and
anticipated wave reflection as compared with PPH. It was
also suggested that pulsatile pressure is highly dependent on
the prevailing MPAP in patients with pulmonary hyperten-
sion. The differences in wave reflection could contribute to
differences in the pulsatile component of right ventricular
afterload between PPH and CPTE.
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